HIMS insider buying and SEC filings, explained
Hims & Hers Health, Inc. · CIK 1773751
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$1.2M
Insiders who bought
1
Sold (not marked 10b5-1)
$98K
Planned sales (10b5-1)
$19.3M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 28, 2026 | Planned (10b5-1) | Soleil Boughton (Chief Legal Officer) sold 3,462 shares at $27.60 ($96K), marked as a 10b5-1 plan trade. Holdings down 1% to 293,886 shares. | SEC filing Filed Oct 29, 2026, 4:11 PM ET |
| Oct 14, 2026 | Planned (10b5-1) | Soleil Boughton (Chief Legal Officer) sold 3,461 shares at $29.06 ($101K), marked as a 10b5-1 plan trade. Holdings down 1% to 297,348 shares. | SEC filing Filed Oct 15, 2026, 4:44 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 2,000 shares at $29.70 ($59K), marked as a 10b5-1 plan trade. Holdings down 1% to 234,527 shares. | SEC filing Filed Oct 2, 2026, 4:32 PM ET |
| Sep 30, 2026 | Planned (10b5-1) | Soleil Boughton (Chief Legal Officer) sold 3,461 shares at $29.17 ($101K), marked as a 10b5-1 plan trade. Holdings down 1% to 300,809 shares. | SEC filing Filed Oct 2, 2026, 4:31 PM ET |
| Sep 22, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 29,277 shares at $29.95 ($877K), marked as a 10b5-1 plan trade. Holdings down 11% to 236,527 shares. | SEC filing Filed Sep 23, 2026 |
| Sep 17, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 12,313 shares at $28.82 ($355K), marked as a 10b5-1 plan trade. Holdings down 5% to 251,804 shares. | SEC filing Filed Sep 18, 2026 |
| Sep 16, 2026 | Planned (10b5-1) | Soleil Boughton (Chief Legal Officer) sold 6,236 shares at $27.86 ($174K), marked as a 10b5-1 plan trade. Holdings down 2% to 304,270 shares. | SEC filing Filed Sep 17, 2026 |
| Sep 15, 2026 | Planned (10b5-1) | Mohamed Elshenawy (CTO) sold 7,954 shares at $28.39 ($226K), marked as a 10b5-1 plan trade. Holdings down 4% to 185,556 shares. | SEC filing Filed Sep 17, 2026 |
| Sep 15, 2026 | Planned (10b5-1) | Michael Chi (President / COO) sold 14,027 shares at $28.39 ($398K), marked as a 10b5-1 plan trade. Holdings down 3% to 456,660 shares. | SEC filing Filed Sep 17, 2026 |
| Sep 2, 2026 | Planned (10b5-1) | Soleil Boughton (Chief Legal Officer) sold 3,458 shares at $28.33 ($98K), marked as a 10b5-1 plan trade. Holdings down 1% to 310,506 shares. | SEC filing Filed Sep 3, 2026 |
| Aug 19, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 4,938 shares at $29.99 ($148K), marked as a 10b5-1 plan trade. Holdings down 2% to 264,117 shares. | SEC filing Filed Aug 20, 2026 |
| Aug 19, 2026 | Planned (10b5-1) | Soleil Boughton (Chief Legal Officer) sold 25,111 shares at $27.55 ($692K), marked as a 10b5-1 plan trade. Holdings down 7% to 313,964 shares. | SEC filing Filed Aug 20, 2026 |
| Aug 18, 2026 | Planned (10b5-1) | Deborah M. Autor (Chief Policy Officer and Director) sold 16,773 shares at $27.85 ($467K), marked as a 10b5-1 plan trade. Holdings down 26% to 48,961 shares. | SEC filing Filed Aug 20, 2026 |
| Jun 18–Aug 17, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 64,771 shares between Jun 18 and Aug 17 at about $34.05 ($2.2M), marked as a 10b5-1 plan trade. Holdings down 20% to 264,117 shares. | SEC filing Filed Aug 18, 2026 |
| Jul 17, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 7,163 shares at $31.99 ($229K), marked as a 10b5-1 plan trade. Holdings down 2% to 284,321 shares. | SEC filing Filed Jul 20, 2026 |
| Jul 6, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 7,163 shares at $36.49 ($261K), marked as a 10b5-1 plan trade. Holdings down 2% to 284,321 shares. | SEC filing Filed Jul 7, 2026 |
| Jun 22, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 18,197 shares at $34.03 ($619K), marked as a 10b5-1 plan trade. Holdings down 6% to 284,321 shares. | SEC filing Filed Jun 23, 2026 |
| Jun 18, 2026 | Planned (10b5-1) | Patrick Harrison Carroll (Chief Medical Officer) sold 23,726 shares at $35.00 ($830K), marked as a 10b5-1 plan trade. Holdings down 12% to 181,861 shares. | SEC filing Filed Jun 23, 2026 |
| Jun 17, 2026 | Planned (10b5-1) | Michael Chi (President / COO) sold 14,027 shares at $31.50 ($442K), marked as a 10b5-1 plan trade. Holdings down 3% to 432,124 shares. | SEC filing Filed Jun 17, 2026 |
| Jun 16–17, 2026 | Planned (10b5-1) | Irene Becklund (Pao) sold 12,063 shares between Jun 16 and Jun 17 at about $30.72 ($371K), marked as a 10b5-1 plan trade. Holdings down 64% to 6,790 shares. | SEC filing Filed Jun 17, 2026 |
| Jun 17, 2026 | Planned (10b5-1) | Mohamed Elshenawy (CTO) sold 30,040 shares at $31.50 ($946K), marked as a 10b5-1 plan trade. Holdings down 23% to 101,023 shares. | SEC filing Filed Jun 17, 2026 |
| May 26, 2026 | Purchase (code P) | David B. Wells (Director) bought 48,400 shares at $24.24 ($1.2M), reported as a purchase (code P). Holdings up 27% to 224,417 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 26, 2026 |
| May 18, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 7,950 shares at $23.64 ($188K), marked as a 10b5-1 plan trade. Holdings down 3% to 262,954 shares. | SEC filing Filed May 19, 2026 |
| Apr 20, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 19,645 shares at $29.96 ($589K), marked as a 10b5-1 plan trade. Holdings down 7% to 262,954 shares. | SEC filing Filed Apr 22, 2026 |
| Apr 20, 2026 | Planned (10b5-1) | Soleil Boughton (Chief Legal Officer) sold 9,463 shares at $30.00 ($284K), marked as a 10b5-1 plan trade. Holdings down 3% to 299,368 shares. | SEC filing Filed Apr 22, 2026 |
| Apr 16–17, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 54,927 shares between Apr 16 and Apr 17 at about $26.53 ($1.5M), marked as a 10b5-1 plan trade. Holdings down 17% to 270,046 shares. | SEC filing Filed Apr 20, 2026 |
| Apr 6, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 3,975 shares at $19.98 ($79K), marked as a 10b5-1 plan trade. Holdings down 1% to 318,789 shares. | SEC filing Filed Apr 7, 2026 |
| Mar 20, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 9,217 shares at $23.77 ($219K), marked as a 10b5-1 plan trade. Holdings down 3% to 318,789 shares. | SEC filing Filed Mar 24, 2026 |
| Mar 17, 2026 | Planned (10b5-1) | Michael Chi (President / COO) sold 97,289 shares at $24.69 ($2.4M), marked as a 10b5-1 plan trade. Holdings down 19% to 407,282 shares. | SEC filing Filed Mar 18, 2026 |
| Mar 17, 2026 | Planned (10b5-1) | Irene Becklund (Pao) sold 5,529 shares at $24.69 ($137K), marked as a 10b5-1 plan trade. Holdings down 39% to 8,752 shares. | SEC filing Filed Mar 18, 2026 |
| Mar 17, 2026 | Planned (10b5-1) | Soleil Boughton (Chief Legal Officer) sold 4,812 shares at $24.69 ($119K), marked as a 10b5-1 plan trade. Holdings down 2% to 308,831 shares. | SEC filing Filed Mar 18, 2026 |
| Feb 27, 2026 | Planned (10b5-1) | Soleil Boughton (Chief Legal Officer) sold 4,651 shares at $15.21 ($71K), marked as a 10b5-1 plan trade. Holdings down 1% to 440,972 shares. | SEC filing Filed Mar 2, 2026 |
| Feb 3, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 5,262 shares at $26.44 ($139K), marked as a 10b5-1 plan trade. Holdings down 5% to 91,617 shares. | SEC filing Filed Feb 4, 2026 |
| Jan 20, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 9,067 shares at $30.34 ($275K), marked as a 10b5-1 plan trade. Holdings down 9% to 91,617 shares. | SEC filing Filed Jan 21, 2026 |
| Jan 5, 2026 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 9,070 shares at $33.79 ($306K), marked as a 10b5-1 plan trade. Holdings down 9% to 91,617 shares. | SEC filing Filed Jan 7, 2026 |
| Dec 22, 2025 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 23,090 shares at $35.72 ($825K), marked as a 10b5-1 plan trade. Holdings down 20% to 94,333 shares. | SEC filing Filed Dec 23, 2025 |
| Dec 17, 2025 | Planned (10b5-1) | Michael Chi (President / COO) sold 13,750 shares at $36.71 ($505K), marked as a 10b5-1 plan trade. Holdings down 4% to 305,161 shares. | SEC filing Filed Dec 18, 2025 |
| Dec 17, 2025 | Planned (10b5-1) | Irene Becklund (Pao) sold 8,411 shares at $36.71 ($309K), marked as a 10b5-1 plan trade. Holdings down 80% to 2,126 shares. | SEC filing Filed Dec 18, 2025 |
| Dec 17, 2025 | Planned (10b5-1) | Deborah M. Autor (Chief Policy Officer and Director) sold 7,054 shares at $36.71 ($259K), marked as a 10b5-1 plan trade. Holdings down 53% to 6,175 shares. | SEC filing Filed Dec 18, 2025 |
| Dec 17, 2025 | Planned (10b5-1) | Patrick Harrison Carroll (Chief Medical Officer and Director) sold 10,021 shares at $36.71 ($368K), marked as a 10b5-1 plan trade. Holdings down 6% to 169,940 shares. | SEC filing Filed Dec 18, 2025 |
| Dec 9, 2025 | Sale | Garcia Andrea G Perez (Director) sold 2,500 shares at $39.17 ($98K). Holdings down 3% to 80,166 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 10, 2025 |
| Nov 24, 2025 | Planned (10b5-1) | Soleil Boughton (Chief Legal Officer) sold 2,631 shares at $35.22 ($93K), marked as a 10b5-1 plan trade. Holdings down 2% to 153,225 shares. | SEC filing Filed Nov 25, 2025 |
| Nov 17, 2025 | Planned (10b5-1) | Oluyemi Okupe (CFO) sold 23,187 shares at $36.81 ($854K), marked as a 10b5-1 plan trade. Holdings down 25% to 70,232 shares. | SEC filing Filed Nov 19, 2025 |
| Nov 10, 2025 | Planned (10b5-1) | Soleil Boughton (Chief Legal Officer) sold 2,637 shares at $42.53 ($112K), marked as a 10b5-1 plan trade. Holdings down 2% to 155,856 shares. | SEC filing Filed Nov 12, 2025 |
87 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow HIMS in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.